Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
157.52
Dollar change
-7.41
Percentage change
-4.49
%
IndexS&P 500 P/E28.82 EPS (ttm)5.47 Insider Own0.11% Shs Outstand448.47M Perf Week-8.11%
Market Cap70.54B Forward P/E22.93 EPS next Y6.87 Insider Trans-0.77% Shs Float446.90M Perf Month-5.77%
Income2.49B PEG3.20 EPS next Q1.40 Inst Own94.98% Short Float1.92% Perf Quarter-9.45%
Sales9.26B P/S7.62 EPS this Y4.82% Inst Trans-2.11% Short Ratio3.17 Perf Half Y-14.10%
Book/sh10.64 P/B14.81 EPS next Y10.69% ROA17.43% Short Interest8.58M Perf Year-14.15%
Cash/sh4.44 P/C35.50 EPS next 5Y9.00% ROE50.91% 52W Range144.80 - 200.53 Perf YTD-3.32%
Dividend Est.1.97 (1.25%) P/FCF30.69 EPS past 5Y11.91% ROI24.46% 52W High-21.45% Beta0.94
Dividend TTM1.80 (1.14%) Quick Ratio1.08 Sales past 5Y8.22% Gross Margin69.10% 52W Low8.78% ATR (14)5.04
Dividend Ex-DateApr 21, 2025 Current Ratio1.75 EPS Y/Y TTM7.70% Oper. Margin36.65% RSI (14)32.36 Volatility3.59% 2.53%
Employees13800 Debt/Eq1.42 Sales Y/Y TTM8.33% Profit Margin26.86% Recom1.55 Target Price212.80
Option/ShortYes / Yes LT Debt/Eq1.13 EPS Q/Q12.87% Payout32.86% Rel Volume2.82 Prev Close164.93
Sales Surprise0.86% EPS Surprise2.77% Sales Q/Q4.70% EarningsFeb 13 BMO Avg Volume2.70M Price157.52
SMA20-7.36% SMA50-7.02% SMA200-11.17% Trades Volume7,612,517 Change-4.49%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Initiated Leerink Partners Outperform $215
Jul-25-24Initiated BTIG Research Buy $220
Jan-12-24Reiterated Stifel Buy $195 → $215
Dec-19-23Resumed Jefferies Buy $230
Dec-07-23Initiated Exane BNP Paribas Outperform $237
Sep-06-23Initiated HSBC Securities Buy $230
Jul-12-22Initiated Piper Sandler Overweight $205
Nov-18-21Initiated Morgan Stanley Overweight $40
Nov-18-21Initiated Morgan Stanley Overweight $264
Aug-05-21Resumed Credit Suisse Outperform $206
Feb-17-25 02:45AM
Feb-14-25 05:15PM
01:00PM
02:12AM
Feb-13-25 11:58PM
06:03PM Loading…
06:03PM
04:12PM
03:24PM
01:59PM
12:24PM
11:30AM
09:30AM
08:47AM
08:10AM
07:58AM
07:54AM Loading…
07:54AM
07:05AM
07:00AM
Feb-12-25 08:09AM
Feb-10-25 09:16AM
Feb-08-25 09:23AM
Feb-07-25 02:14AM
Feb-06-25 04:15PM
10:01AM
Feb-04-25 06:15PM
10:41AM
08:00AM
Jan-29-25 06:15PM
04:20PM
Jan-28-25 02:34PM
03:09PM Loading…
Jan-24-25 03:09PM
Jan-22-25 12:10PM
Jan-17-25 07:30AM
Jan-14-25 02:54PM
Jan-08-25 06:15PM
Jan-07-25 04:15PM
08:30AM
Dec-30-24 04:31PM
09:45AM
Dec-26-24 11:35AM
Dec-20-24 06:15PM
Dec-19-24 04:45AM
Dec-17-24 12:02PM
Dec-13-24 09:45AM
08:45AM
Dec-12-24 04:15PM
Dec-10-24 09:43AM
Dec-04-24 11:30AM
Nov-30-24 04:20PM
Nov-27-24 09:45AM
Nov-25-24 03:03PM
08:45AM
Nov-19-24 08:30AM
Nov-13-24 07:35PM
Nov-11-24 09:45AM
09:20AM
Nov-08-24 05:40AM
02:16AM
Nov-07-24 08:41AM
08:30AM
Nov-05-24 02:04AM
12:02AM
Nov-04-24 11:55PM
04:06PM
01:17PM
12:30PM
10:22AM
09:30AM
09:05AM
08:10AM
07:58AM
07:06AM
07:00AM
Oct-31-24 04:10PM
Oct-30-24 09:15AM
Oct-28-24 06:15PM
10:01AM
Oct-24-24 06:23PM
Oct-21-24 12:10PM
Oct-10-24 04:23PM
Oct-09-24 06:43PM
Sep-28-24 09:58PM
Sep-26-24 09:00AM
Sep-19-24 08:30AM
Sep-16-24 06:20PM
Sep-13-24 06:15PM
Sep-06-24 07:31AM
Sep-05-24 11:31AM
Aug-26-24 12:15PM
Aug-20-24 08:30AM
Aug-19-24 12:39PM
Aug-07-24 03:34PM
09:35AM
09:30AM
09:30AM
02:04AM
01:01AM
Aug-06-24 06:04PM
05:01PM
04:26PM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lagano RoxanneExecutive Vice PresidentFeb 11 '25Sale171.1832655,80516,107Feb 11 05:15 PM
Lagano RoxanneOfficerFeb 11 '25Proposed Sale171.1832655,805Feb 11 04:33 PM
Polzer Robert JExecutive Vice PresidentNov 25 '24Option Exercise161.633,477561,9856,726Nov 26 04:27 PM
Polzer Robert JExecutive Vice PresidentNov 25 '24Sale177.463,477617,0283,249Nov 26 04:27 PM
Polzer Robert JOfficerNov 25 '24Proposed Sale177.463,477617,029Nov 25 04:20 PM
Lagano RoxanneExecutive Vice PresidentApr 18 '24Sale151.17923139,53014,800Apr 18 04:37 PM
Lagano RoxanneExecutive Vice PresidentMar 18 '24Sale173.33923159,98415,723Mar 18 04:33 PM
Reed Willie MDirectorMar 11 '24Sale182.681,370250,2659,994Mar 12 04:19 PM
PECK KRISTIN CChief Executive OfficerFeb 20 '24Option Exercise46.0913,000599,17092,366Feb 21 04:39 PM
PECK KRISTIN CChief Executive OfficerFeb 20 '24Sale187.2013,0002,433,63679,366Feb 21 04:39 PM
Lagano RoxanneExecutive Vice PresidentFeb 20 '24Sale187.30923172,87816,646Feb 21 04:38 PM